Published in Cell Chem Biol on September 01, 2016
Functional RNA structures throughout the Hepatitis C Virus genome. Curr Opin Virol (2017) 0.75
Amiloride as a new RNA-binding scaffold with activity against HIV-1 TAR. Medchemcomm (2017) 0.75
Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron (2011) 20.15
Non-coding RNAs in human disease. Nat Rev Genet (2011) 11.40
Thiamine derivatives bind messenger RNAs directly to regulate bacterial gene expression. Nature (2002) 8.14
RNA and disease. Cell (2009) 7.98
Architecture and secondary structure of an entire HIV-1 RNA genome. Nature (2009) 6.12
Hepatitis C virus IRES RNA-induced changes in the conformation of the 40s ribosomal subunit. Science (2001) 4.79
Targeting RNA with small molecules. Chem Rev (2008) 3.66
The bacterial ribosome as a target for antibiotics. Nat Rev Microbiol (2005) 3.27
Motor neuron disease. SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy. Science (2014) 3.10
Riboswitches as antibacterial drug targets. Nat Biotechnol (2006) 3.01
Long noncoding RNAs and the genetics of cancer. Br J Cancer (2013) 2.98
Antibacterial lysine analogs that target lysine riboswitches. Nat Chem Biol (2006) 2.94
Structure of HCV IRES domain II determined by NMR. Nat Struct Biol (2003) 2.93
Structure of the hepatitis C virus IRES bound to the human 80S ribosome: remodeling of the HCV IRES. Structure (2005) 2.82
Pervasive transcription of the human genome produces thousands of previously unidentified long intergenic noncoding RNAs. PLoS Genet (2013) 2.46
Rational design of ligands targeting triplet repeating transcripts that cause RNA dominant disease: application to myotonic muscular dystrophy type 1 and spinocerebellar ataxia type 3. J Am Chem Soc (2009) 2.06
RNA SHAPE analysis in living cells. Nat Chem Biol (2012) 2.02
Small-molecule inhibitors of microrna miR-21 function. Angew Chem Int Ed Engl (2008) 2.00
Recent advances in developing small molecules targeting RNA. ACS Chem Biol (2012) 1.97
SMN2 splice modulators enhance U1-pre-mRNA association and rescue SMA mice. Nat Chem Biol (2015) 1.93
Conformational inhibition of the hepatitis C virus internal ribosome entry site RNA. Nat Chem Biol (2009) 1.84
Two-dimensional combinatorial screening identifies specific aminoglycoside-RNA internal loop partners. J Am Chem Soc (2008) 1.84
Adaptive ligand binding by the purine riboswitch in the recognition of guanine and adenine analogs. Structure (2009) 1.84
Drugs targeting the ribosome. Curr Opin Struct Biol (2005) 1.77
Dynamic combinatorial selection of molecules capable of inhibiting the (CUG) repeat RNA-MBNL1 interaction in vitro: discovery of lead compounds targeting myotonic dystrophy (DM1). J Am Chem Soc (2008) 1.70
Discovery of an inhibitor of a transcription factor using small molecule microarrays and diversity-oriented synthesis. J Am Chem Soc (2003) 1.69
SAR by MS: discovery of a new class of RNA-binding small molecules for the hepatitis C virus: internal ribosome entry site IIA subdomain. J Med Chem (2005) 1.59
Small molecule modifiers of microRNA miR-122 function for the treatment of hepatitis C virus infection and hepatocellular carcinoma. J Am Chem Soc (2010) 1.53
A robust small-molecule microarray platform for screening cell lysates. Chem Biol (2006) 1.52
Roseoflavin is a natural antibacterial compound that binds to FMN riboswitches and regulates gene expression. RNA Biol (2009) 1.50
Structure of a hepatitis C virus RNA domain in complex with a translation inhibitor reveals a binding mode reminiscent of riboswitches. Proc Natl Acad Sci U S A (2012) 1.47
Functional architecture of HCV IRES domain II stabilized by divalent metal ions in the crystal and in solution. Angew Chem Int Ed Engl (2007) 1.46
Rationally designed small molecules targeting the RNA that causes myotonic dystrophy type 1 are potently bioactive. ACS Chem Biol (2012) 1.43
Sequence-based design of bioactive small molecules that target precursor microRNAs. Nat Chem Biol (2014) 1.41
Discovery of a biomarker and lead small molecules to target r(GGGGCC)-associated defects in c9FTD/ALS. Neuron (2014) 1.37
Discovery of selective bioactive small molecules by targeting an RNA dynamic ensemble. Nat Chem Biol (2011) 1.31
Design and antimicrobial action of purine analogues that bind Guanine riboswitches. ACS Chem Biol (2009) 1.29
Posttranscriptional RNA Modifications: playing metabolic games in a cell's chemical Legoland. Chem Biol (2013) 1.25
The pivotal regulatory landscape of RNA modifications. Annu Rev Genomics Hum Genet (2014) 1.23
The RFN riboswitch of Bacillus subtilis is a target for the antibiotic roseoflavin produced by Streptomyces davawensis. RNA Biol (2009) 1.21
Identification of a selective small-molecule ligand for HIV-1 frameshift-inducing stem-loop RNA from an 11,325 member resin bound dynamic combinatorial library. J Am Chem Soc (2007) 1.19
A method for the covalent capture and screening of diverse small molecules in a microarray format. Nat Protoc (2006) 1.19
Structure-activity relationships through sequencing (StARTS) defines optimal and suboptimal RNA motif targets for small molecules. Angew Chem Int Ed Engl (2010) 1.11
Selective small-molecule inhibition of an RNA structural element. Nature (2015) 1.11
From dynamic combinatorial 'hit' to lead: in vitro and in vivo activity of compounds targeting the pathogenic RNAs that cause myotonic dystrophy. Nucleic Acids Res (2012) 1.10
Development and application of a high-throughput assay for glmS riboswitch activators. RNA Biol (2006) 1.05
Screening for inhibitors of the hepatitis C virus internal ribosome entry site RNA. Bioorg Med Chem (2013) 1.04
Induction and reversal of myotonic dystrophy type 1 pre-mRNA splicing defects by small molecules. Nat Commun (2013) 1.01
High-affinity recognition of HIV-1 frameshift-stimulating RNA alters frameshifting in vitro and interferes with HIV-1 infectivity. J Med Chem (2014) 1.01
Small-molecule quadruplex-targeted drug discovery. Bioorg Med Chem Lett (2014) 1.00
The riboflavin analog roseoflavin targets an FMN-riboswitch and blocks Listeria monocytogenes growth, but also stimulates virulence gene-expression and infection. RNA Biol (2011) 1.00
Two high-throughput screening assays for aberrant RNA-protein interactions in myotonic dystrophy type 1. Anal Bioanal Chem (2012) 0.99
Triplet repeats in transcripts: structural insights into RNA toxicity. Biol Chem (2012) 0.96
An overview of the clinical application of antisense oligonucleotides for RNA-targeting therapies. Curr Opin Pharmacol (2015) 0.96
Targeting toxic RNAs that cause myotonic dystrophy type 1 (DM1) with a bisamidinium inhibitor. J Am Chem Soc (2014) 0.96
Validating fragment-based drug discovery for biological RNAs: lead fragments bind and remodel the TPP riboswitch specifically. Chem Biol (2014) 0.95
Aminoglycoside microarrays to study antibiotic resistance. Angew Chem Int Ed Engl (2004) 0.95
Therapeutic targeting of HCV internal ribosomal entry site RNA. Antivir Chem Chemother (2011) 0.94
Strategies for recognition of stem-loop RNA structures by synthetic ligands: application to the HIV-1 frameshift stimulatory sequence. J Med Chem (2010) 0.92
TERRA and the state of the telomere. Nat Struct Mol Biol (2015) 0.91
Advances in the determination of nucleic acid conformational ensembles. Annu Rev Phys Chem (2013) 0.91
Carba-sugars activate the glmS-riboswitch of Staphylococcus aureus. ACS Chem Biol (2011) 0.90
Recent discoveries and applications involving small-molecule microarrays. Curr Opin Chem Biol (2013) 0.90
Nucleic Acid Modifications in Regulation of Gene Expression. Cell Chem Biol (2016) 0.90
Cryo-EM structure of Hepatitis C virus IRES bound to the human ribosome at 3.9-Å resolution. Nat Commun (2015) 0.89
Recognition of nucleic acid junctions using triptycene-based molecules. Angew Chem Int Ed Engl (2014) 0.89
A modular approach to synthetic RNA binders of the hepatitis C virus internal ribosome entry site. Chembiochem (2010) 0.87
The expanding view of RNA and DNA function. Chem Biol (2014) 0.87
Methods to enable the design of bioactive small molecules targeting RNA. Org Biomol Chem (2014) 0.86
A small-molecule probe induces a conformation in HIV TAR RNA capable of binding drug-like fragments. J Mol Biol (2011) 0.85
Visualizing the global secondary structure of a viral RNA genome with cryo-electron microscopy. RNA (2015) 0.85
Aryl-substituted aminobenzimidazoles targeting the hepatitis C virus internal ribosome entry site. Bioorg Med Chem Lett (2014) 0.85
Novel riboswitch-binding flavin analog that protects mice against Clostridium difficile infection without inhibiting cecal flora. Antimicrob Agents Chemother (2015) 0.84
Triptycene-based small molecules modulate (CAG)·(CTG) repeat junctions. Chem Sci (2015) 0.83
Identification of RNA pseudoknot-binding ligand that inhibits the -1 ribosomal frameshifting of SARS-coronavirus by structure-based virtual screening. J Am Chem Soc (2011) 0.83
Small Molecule Microarrays Enable the Identification of a Selective, Quadruplex-Binding Inhibitor of MYC Expression. ACS Chem Biol (2015) 0.82
Blast from the Past: Reassessing Forgotten Translation Inhibitors, Antibiotic Selectivity, and Resistance Mechanisms to Aid Drug Development. Mol Cell (2015) 0.82
A novel small-molecule binds to the influenza A virus RNA promoter and inhibits viral replication. Chem Commun (Camb) (2013) 0.82
N-Methylation as a Strategy for Enhancing the Affinity and Selectivity of RNA-binding Peptides: Application to the HIV-1 Frameshift-Stimulating RNA. ACS Chem Biol (2015) 0.82
2-Aminobenzoxazole ligands of the hepatitis C virus internal ribosome entry site. Bioorg Med Chem Lett (2014) 0.82
Identification of biologically active, HIV TAR RNA-binding small molecules using small molecule microarrays. J Am Chem Soc (2014) 0.81
Studying a Drug-like, RNA-Focused Small Molecule Library Identifies Compounds That Inhibit RNA Toxicity in Myotonic Dystrophy. ACS Chem Biol (2015) 0.81
Small Molecule Inhibition of miR-544 Biogenesis Disrupts Adaptive Responses to Hypoxia by Modulating ATM-mTOR Signaling. ACS Chem Biol (2015) 0.81
Molecular architecture of the ribosome-bound Hepatitis C Virus internal ribosomal entry site RNA. EMBO J (2015) 0.81
Synthesis of 9-Substituted Triptycene Building Blocks for Solid-Phase Diversification and Nucleic Acid Junction Targeting. Org Lett (2016) 0.80
Discovery of selective ligands for telomeric RNA G-quadruplexes (TERRA) through 19F-NMR based fragment screening. ACS Chem Biol (2014) 0.79
Bottom-up design of small molecules that stimulate exon 10 skipping in mutant MAPT pre-mRNA. Chembiochem (2014) 0.79
Rationally Designed Small Molecules That Target Both the DNA and RNA Causing Myotonic Dystrophy Type 1. J Am Chem Soc (2015) 0.79
Fragment based search for small molecule inhibitors of HIV-1 Tat-TAR. Bioorg Med Chem Lett (2014) 0.79
Structure based approaches for targeting non-coding RNAs with small molecules. Curr Opin Struct Biol (2015) 0.79
Identification of ligand analogues that control c-di-GMP riboswitches. ACS Chem Biol (2012) 0.78
Small-angle X-ray scattering: a bridge between RNA secondary structures and three-dimensional topological structures. Curr Opin Struct Biol (2015) 0.78
Aminoglycoside antibiotics bind to the influenza A virus RNA promoter. Mol Biosyst (2012) 0.78
Targeting Influenza A Virus RNA Promoter. Chem Biol Drug Des (2015) 0.77
Aryl amide small-molecule inhibitors of microRNA miR-21 function. Bioorg Med Chem Lett (2015) 0.76
Targeting the HIV RNA genome: high-hanging fruit only needs a longer ladder. Curr Top Microbiol Immunol (2015) 0.76
Bridgehead-Substituted Triptycenes for Discovery of Nucleic Acid Junction Binders. Org Lett (2016) 0.76
Anti-frameshifting ligand reduces the conformational plasticity of the SARS virus pseudoknot. J Am Chem Soc (2014) 0.76
Binding site druggability assessment in fragment-based drug design. Methods Mol Biol (2015) 0.75
Modulation of the E. coli rpoH Temperature Sensor with Triptycene-Based Small Molecules. Angew Chem Int Ed Engl (2016) 0.75